Skip to main content
All lobbying filings

TIBER CREEK GROUP

TIBER CREEK GROUP filed a Q2 report for ORGANON, LLC on July 18, 2026, reporting $60,000 in lobbying income.

Lobbying for ORGANON, LLC · Pharmaceutical Company.

All filings by TIBER CREEK GROUP · Everything ORGANON, LLC has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 18, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Health Issues

Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Servicemember Quality of Life Improvement; Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.

Medicare/Medicaid

Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).

Budget/Appropriations

Issues related to women's health.

 Bills named in this filing 2
  • H.R. 8800
    National Defense Authorization Act for Fiscal Year 2027
  • S. 4784
    National Defense Authorization Act for Fiscal Year 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem